Idhifa Tablet, Film Coated
Product Images NDC 59572-710

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Idhifa (NDC 59572-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Idhifa 01)

FDA Label Image

50 mg Label (Idhifa 02)

This text provides information about the prescription drug "IDHIFA" with the active ingredient enasidenib. The drug is dispensed in 30-tablet containers and must be stored in its original container with a desiccant. Tablets should be swallowed whole and not chewed or split. Each tablet contains 50mg of enasidenib mesylate. The drug should be stored between 20°C-25°C with excursions permitted between 15°C-30°C. The text also provides the manufacturer's name, Colgene Corporation, and the licensing company, AosPramaceuicah e, located in Switzerland. Prescribing information for dosing and administration is available.*

FDA Label Image

100 mg Label (Idhifa 03)

This is a description of a prescription drug called IDHIFA, with the generic name enasidenib. It comes in the form of tablets that should be swallowed whole and not chewed or split. It is dispensed in its original container with a desiccant, and the bottle should be kept tightly closed. The recommended storage temperature range is between 20°C and 25°C, and should not exceed 30°C (86°F). The text includes the manufacturer's name and contact information. This description is primarily for informational purposes only and does not provide any medical advice.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.